0001209191-23-014958.txt : 20230302 0001209191-23-014958.hdr.sgml : 20230302 20230302194135 ACCESSION NUMBER: 0001209191-23-014958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shabshab Nabil CENTRAL INDEX KEY: 0001568903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36309 FILM NUMBER: 23701129 MAIL ADDRESS: STREET 1: BECTON, DICKINSON AND COMPANY STREET 2: 1 BECTON DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inogen Inc CENTRAL INDEX KEY: 0001294133 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 BUSINESS PHONE: 805-562-0500 MAIL ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-28 0 0001294133 Inogen Inc INGN 0001568903 Shabshab Nabil C/O INOGEN, INC. 301 COROMAR DRIVE GOLETA CA 93117 1 1 0 0 CEO and President Common Stock 2023-03-01 4 A 0 7810 0.00 A 29036 D Common Stock 2023-03-01 4 F 0 3873 15.56 D 25163 D Common Stock 2023-03-01 4 M 0 16702 0.00 A 41865 D Common Stock 2023-03-01 4 F 0 8362 15.56 D 33503 D Restricted Stock Unit 2023-03-01 4 M 0 1568 0.00 D Common Stock 1568 7841 D Restricted Stock Unit 2023-03-01 4 M 0 2117 0.00 D Common Stock 2117 8468 D Restricted Stock Unit 2023-03-01 4 M 0 13017 0.00 D Common Stock 13017 26034 D Restricted Stock Unit 2023-02-28 4 A 0 70197 0.00 A Common Stock 70197 70197 D The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022. The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted stock award granted on March 1, 2022 and vested on March 1, 2023. The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023. Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. /s/ Leslyn Cicekli, as Attorney-in-Fact 2023-03-02